Ryan Long, director of congressional relations and senior research fellow at the Paragon Health Institute, testifies before the Senate HELP Committee on April 16.
Eli Lilly defended its policy requiring covered entities to report 340B claims data for in-house pharmacy utilization in a late-January letter to HRSA.
